Quantitative real-time PCR: A powerful ally in cancer research

Trends in Molecular Medicine

Volumn 9, Issue 5, 2003, Pages 189-195

  Mocellin, Simone ^a   Rossi, Carlo R ^a   Pilati, Pierluigi ^a   Nitti, Donato ^a   Marincola, Francesco M ^b  

^a UNIVERSITY OF PADOVA   (Italy)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; BIOTECHNOLOGY; CANCER IMMUNOLOGY; CANCER RESEARCH; CARCINOGENESIS; GENE EXPRESSION; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; REVIEW;

EID: 0037495962     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(03)00047-9     Document Type: Review

References (63)

1. Brown, P.O. and Botstein, D. (1999) Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21, 33-37
2. De Arruda, M. et al. (2002) Invader technology for DNA and RNA analysis: principles and applications. Expert Rev. Mol. Diagn. 2, 487-496
3. Zhang, L. et al. (1997) Gene expression profiles in normal and cancer cells. Science 276, 1268-1272
4. Heid, C.A. et al. (1996) Real time quantitative PCR. Genome Res. 6, 986-994
5. Klein, D. (2002) Quantification using real-time PCR technology: applications and limitations. Trends Mol. Med. 8, 257-260
6. Higuchi, R. et al. (1992) Simultaneous amplification and detection of specific DNA sequences. Biotechnology 10, 413-417
7. Lee, L.G. et al. (1993) Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 21, 3761-3766
8. Lie, Y.S. and Petropoulos, C.J. (1998) Advances in quantitative PCR technology: 5′ nuclease assays. Curr. Opin. Biotechnol. 9, 43-48
9. Didenko, V.V. (2001) DNA probes using fluorescence resonance energy transfer (FRET): designs and applications. BioTechniques 31, 1106-1116
10. Wittwer, C.T. et al. (2001) Real-time multiplex PCR assays. Methods 25, 430-442
11. Ginzinger, D.G. (2002) Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. Exp. Hematol. 30, 503-512
12. Zhu, G. et al. (2001) Fudenine, a C-terminal truncated rat homologue of mouse prominin, is blood glucose-regulated and can up-regulate the expression ofGAPDH. Biochem. Biophys. Res. Commun. 281, 951-956
13. Goidin, D. et al. (2001) Ribosomal 18S RNA prevails over glyceraldehyde-3-phosphate dehydrogenase and β-actin genes as internal standard for quantitative comparison of mRNA levels in invasive and noninvasive human melanoma cell subpopulations. Anal. Biochem. 295, 17-21
14. Kammula, U.S. et al. (2000) Real-time quantitative polymerase chain reaction assessment of immune reactivity in melanoma patients after tumor peptide vaccination. J. Natl. Cancer Inst. 92, 1336-1344
15. Seeger, K. et al. (2001) Molecular quantification of response to therapy and remission status in TEL-AML1-positive childhood ALL by real-time reverse transcription polymerase chain reaction. Cancer Res. 61, 2517-2522
16. Selvey, S. et al. (2001) β-actin - an unsuitable internal control for RT-PCR. Mol. Cell. Probes 15, 307-311
17. Raff, T. et al. (1997) Design and testing of β-actin primers for RT-PCR that do not co-amplify processed pseudogenes. BioTechniques 23, 456-460
18. Solanas, M. et al. (2001) Unsuitability of using ribosomal RNA as loading control for Northern blot analyses related to the imbalance between messenger and ribosomal RNA content in rat mammary tumors. Anal. Biochem. 288, 99-102
19. Bustin, S.A. (2000) Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25, 169-193
20. Vandesompele, J. et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, 0034
21. Deng, G. et al. (1996) Loss ofheterozygosity in normal tissue adjacent to breast carcinomas. Science 274, 2057-2059
22. Bustin, S.A. et al. (2001) Expression of HLA class II in colorectal cancer: evidence for enhanced immunogenicity of microsatellite-instability-positive tumours. Tumour Biol. 22, 294-298
23. Elkahloun, A.G. et al. (2002) In situ gene expression analysis ofcancer using laser capture microdissection, microarrays and real time quantitative PCR. Cancer Biol. Ther. 1, 354-358
24. Emmert-Buck, M.R. et al. (1996) Laser capture microdissection. Science 274, 998-1001
25. Walch, A. et al. (2001) Tissue microdissection techniques in quantitative genome and gene expression analyses. Histochem. Cell Biol. 115, 269-276
26. Wang, E. et al. (2000) High-fidelity mRNA amplification for gene profiling. Nat. Biotechnol. 18, 457-459
27. Drexler, H.G. et al. (1995) Detection of chromosomal translocations in leukemia-lymphoma cells by polymerase chain reaction. Leuk. Lymphoma 19, 359-380
28. Mrozek, K. et al. (2001) Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acate myeloid leukemia: a Cancer and Leukemia Group B Study. J. Clin. Oncol. 19, 2482-2492
29. Marcucci, G. et al. (1998) Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay. Leukemia 12, 1482-1489
30. Krauter, J. et al. (2001) The AML1/MTG8 fusion transcript in t(8;21) positive AML and its implication for the detection of minimal residual disease; malignancy. Hematology 5, 369-381
31. Verhagen, O.J. et al. (2000) Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia. Leukemia 14, 1426-1435
32. Elmaagacli, A.H. et al. (2000) The amount of BCR-ABL fusion transcripts detected by the real-time quantitative polymerase chain reaction method in patients with Philadelphia chromosome positive chronic myeloid leukemia correlates with the disease stage. Ann. Hematol. 79, 424-431
33. Barthe, C. et al. (2001) Expression of interferon-α (IFN-α) receptor 2c at diagnosis is associated with cytogenetic response in IFN-α-treated chronic myeloid leukemia. Blood 97, 3568-3573
34. Luthra, R. et al. (1999) Real-time 5′ → 3′ exonuclease-based PCR assay for detection of the t(11;14)(q13;q32). Am. J. Clin. Pathol. 112, 524-530
35. Hosler, G.A. et al. (1999) Development and validation of a quantitative polymerase chain reaction assay to evaluate minimal residual disease for T-cell acute lymphoblastic leukemia and follicular lymphoma. Am. J. Pathol. 154, 1023-1035
36. Ladetto, M. et al. (2001) A validated real-time quantitative PCR approach shows a correlation between tumor burden and successful ex vivo purging in follicular lymphoma patients. Exp. Hematol. 29, 183-193
37. Diel, I.J. et al. (2000) Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer. Cancer Treat. Rev. 26, 53-65
38. Tsao, H. et al. (2001) A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma. Arch. Dermatol. 137, 325-330
39. Ko, Y. et al. (2000) High percentage of false-positive results of cytokeratin 19 RT-PCR in blood: a model for the analysis ofillegitimate gene expression. Oncology 59, 81-88
40. Bustin, S.A. et al. (1999) Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood ofcolorectal cancer patients. Br. J. Cancer 79, 1813-1820
41. De Vries, T.J. et al. (1999) Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR. Br. J. Cancer 80, 883-891
42. Straub, B. et al. (2001) Detection of prostate-specific antigen RNA before and after radical retropubic prostatectomy and transurethral resection of the prostate using 'Light-Cycler'-based quantitative real-time polymerase chain reaction. Urology 58, 815-820
43. Bosma, A.J. et al. (2002) Detection of circulating breast tumor cells by differential expression of marker genes. Clin. Cancer Res. 8, 1871-1877
44. Van Trappen, P.O. et al. (2001) Molecular quantification and mapping of lymph-node micrometastases in cervical cancer. Lancet 357, 15-20
45. Soong, R. et al. (2001) Quantitative reverse transcription-polymerase chain reaction detection of cytokeratin 20 in noncolorectal lymph nodes. Clin. Cancer Res. 7, 3423-3429
46. Lee, P.P. et al. (1999) Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5, 677-685
47. Panelli, M.C. et al. (2002) The role ofquantitative PCR for the immune monitoring of cancer patients. Expert Opin. Biol. Ther. 2, 537-544
48. Kammula, U.S. et al. (1999) Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens. J. Immunol. 163, 6867-6875
49. + T cells. J. Immunol. 165, 2287-2296
50. Monsurro, V. et al. (2001) Kinetics of TCR use in response to repeated epitope-specific immunization. J. Immunol. 166, 5817-5825
51. Housseau, F. et al. (2002) Quantitative real-time RT-PCR as a method for monitoring T lymphocyte reactivity to full-length tyrosinase protein in vaccinated melanoma patients. J. Immunol. Methods 266, 87-103
52. Wang, E. and Marincola, F.M. (2000) A natural history of melanoma: serial gene expression analysis. Immunol. Today 21, 619-623
53. Ohnmacht, G.A. et al. (2001) Short-term kinetics of tumor antigen expression in response to vaccination. J. Immunol. 167, 1809-1820
54. Mocellin, S. et al. (2001) Kinetics of cytokine expression in melanoma metastases classifies immune responsiveness. Int. J. Cancer 93, 236-242
55. Mocellin, S. et al. (2003) The dual role of IL-10. Trends Immunol. 24, 36-43
56. Barrett, M.T. et al. (1996) Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene 12, 1873-1878
57. Ginzinger, D.G. et al. (2000) Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res. 60, 5405-5409
58. Suzuki, S. et al. (2000) An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer. Cancer Res. 60, 5382-5385
59. Boulay, J.L. et al. (2002) SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer. Br. J. Cancer 87, 630-634
60. Mild, G. et al. (2002) DCR3 locus is a predictive marker for 5-fluorouracil-based adjuvant chemotherapy in colorectal cancer. Int. J. Cancer 102, 254-257
61. Abbaszadegan, M.R. et al. (1997) Automated detection of prevalent mutations in BRCA1 and BRCA2 genes, using a fluorogenic PCR allelic discrimination assay. Genet. Test. 1, 171-180
62. Germer, S. et al. (2000) High-throughput SNP allele-frequency determination in pooled DNA samples by kinetic PCR. Genome Res. 10, 258-266
63. Oliver, D.H. et al. (2000) Use ofsingle nucleotide polymorphisms (SNP) and real-time polymerase chain reaction for bone marrow engraftment analysis. J. Mol. Diagn. 2, 202-208